Literature DB >> 23969511

Assessment of the peripheral ventilatory response to CO2 in heart failure patients: reliability of the single-breath test.

Roberto Maestri1, Claudio Bruschi, Francesca Olmetti, Maria Teresa La Rovere, Gian Domenico Pinna.   

Abstract

The assessment of chemoreflex sensitivity in heart failure patients is gaining increasing interest since recent studies demonstrated that augmented chemosensitivity is an independent predictor of mortality and represents an important pathogenic factor in the development of Cheyne-Stokes respiration. The single-breath CO2 test is a well-established method to quantify peripheral hypercapnic chemoreflex sensitivity. As the original criteria for the computation of the chemoreflex sensitivity in healthy subjects need to be modified in heart failure patients to take into account impaired cardiac function, the effects of such modifications on measurement reliability deserve investigation. Hence, we devised this study to assess the reliability of the single-breath CO2 test in heart failure patients. In 27 clinically stable, mild-to-moderate heart failure patients (age (mean±SD): 64±10 years, left ventricular ejection fraction: 34±7%, NYHA class: 2.7±0.4), the test was administered on two consecutive days in the same conditions. Reliability was assessed by the standard error of measurement (SEM) and by the intraclass correlation coefficient (ICC). The mean value of the chemoreflex sensitivity on the two days was: 0.25 ± 0.12 and 0.24 ± 0.12 l min(-1) mmHg(-1) (p = 0.45), respectively. The SEM was 0.05 l min(-1) mmHg(-1), indicating large intra-subject variability. Consequently, in order to be 95% confident that a real change has occurred between two measurements taken on the same individual (test-retest), the observed difference must be higher than ±0.15 l min(-1) mmHg(-1), which is about 60% of the mean value across our population. The ICC was 0.71, indicating thatintra-subject variability, although high, is a limited (29%) portion of inter-subject variability. Intra-subject variability should be carefully taken into account when using the single-breath CO2 test in assessing changes in individual patients. The observed ICC indicates that this test may provide useful information for diagnostic/classification purposes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23969511     DOI: 10.1088/0967-3334/34/9/1123

Source DB:  PubMed          Journal:  Physiol Meas        ISSN: 0967-3334            Impact factor:   2.833


  4 in total

Review 1.  Pathophysiology and potential clinical applications for testing of peripheral chemosensitivity in heart failure.

Authors:  Piotr Niewinski
Journal:  Curr Heart Fail Rep       Date:  2014-06

2.  Ventilatory oscillations at exercise: effects of hyperoxia, hypercapnia, and acetazolamide.

Authors:  Eric Hermand; François J Lhuissier; Julie Larribaut; Aurélien Pichon; Jean-Paul Richalet
Journal:  Physiol Rep       Date:  2015-06

3.  The Influence of Age on Interaction between Breath-Holding Test and Single-Breath Carbon Dioxide Test.

Authors:  Nikita Trembach; Igor Zabolotskikh
Journal:  Biomed Res Int       Date:  2017-01-31       Impact factor: 3.411

4.  Evaluation of Breath-Holding Test in Assessment of Peripheral Chemoreflex Sensitivity in Patients with Chronic Heart Failure.

Authors:  Nikita Trembach; Igor Zabolotskikh
Journal:  Open Respir Med J       Date:  2017-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.